Joey Armand Muns

Title: Joey Armand Muns: Innovator in Binding Molecules

Introduction

Joey Armand Muns is an inventor based in Hoofddorp, Netherlands. He is currently associated with Linxis B.V. Although he has not yet been granted any patents, his work focuses on innovative binding molecules that target specific receptors involved in various fibrotic conditions.

Latest Patent Applications

Muns has filed several patent applications related to internalizing binding molecules. One of his notable applications is for binding molecules that comprise at least one single variable antibody domain, specifically targeting receptors present on fibrogenic effector cells. This invention aims to facilitate the targeted delivery of anti-fibrotic substances to cells involved in liver fibrosis, lung fibrosis, renal fibrosis, systemic sclerosis, inflammatory bowel disease, and tumor-supporting stromal fibroblasts. The application also includes binding molecules with at least two single variable antibody domains, nucleic acids encoding these molecules, and methods for their preparation. Additionally, he has applied for binding molecules that target receptors involved in cell proliferation or differentiation, particularly focusing on myofibroblasts and hepatic stellate cells.

Conclusion

Joey Armand Muns is making significant strides in the field of binding molecules, with a focus on therapeutic applications for fibrotic diseases. His innovative approaches hold promise for future advancements in medical treatments.